Effect of 5-MCA-NAT, a putative melatonin MT3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes

Journal of Glaucoma

Volumn 13, Issue 5, 2004, Pages 385-388

  Serle, Janet B ^a   Wang, Rong Fang ^a   Peterson, Ward M ^b   Plourde, Robert ^b   Yerxa, Benjamin R ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

5 MCA NAT; Glaucoma; Glaucomatous monkey eye; Intraocular pressure; Melatonin

Indexed keywords

5 METHOXYCARBONYLAMINO N ACETYLTRYPTAMINE; ANTIGLAUCOMA AGENT; MELATONIN; MELATONIN 3 RECEPTOR; MELATONIN 3 RECEPTOR AGONIST; MELATONIN DERIVATIVE; MELATONIN RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SELECTIVITY; FEMALE; GLAUCOMA; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MONKEY; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ANIMALS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLAUCOMA; INTRAOCULAR PRESSURE; MACACA FASCICULARIS; RECEPTORS, MELATONIN; TIME FACTORS; TRYPTAMINES;

EID: 4644223122     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ijg.0000133150.44686.0b     Document Type: Article

References (17)

1. Walt JG, Strutton DR. Evaluation of the utilization of glaucoma surgery before and after the introduction of newer, more potent anti-glaucoma medications. American Academy of Ophthalmology Final Program 2002:144.
2. Witt-Enderby PA, Bennett J, Jarzynka MJ, et al. Melatonin receptors and their regulation: biochemical and structural mechanisms. Life Sci. 2003; 72:2183-2198.
3. Nosjean O, Nicolas JP, Klupsch F, et al. Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2. Biochem Pharmacol. 2001;61:1369-1379.
4. th World Congress of Pharmacology. The Pharmacologist 2002;44(Suppl 1):A46.
5. 3 receptors in the regulation of intraocular pressure in rabbits. Eur J Pharmacol. 2001;416:251-254.
6. Lee PY, Podos SM, Serle JB, et al. Intraocular pressure effects of multiple doses of drugs applied to glaucomatous monkey eyes. Arch Ophthalmol. 1987;105:249-252.
7. Serle JB, Podos SM, Kitazawa Y, et al. A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes. Jpn J Ophthalmol. 1998;42:95-100.
8. Wang RF, Serle JB, Podos SM, et al. The ocular hypotensive effect of the topical carbonic anhydrase inhibitor L-671,152 in glaucomatous monkeys. Arch Ophthalmol. 1990;108:511-513.
9. Wang RF, Schumer RA, Serle JB, et al. A comparison of argon laser and diode laser photocoagulation of the trabecular meshwork to produce the glaucoma monkey model. J Glaucoma. 1998;7:45-49.
10. Luboshitzky R, Yanai D, Shen-Orr Z, et al. Daily and seasonal variations in the concentration of melatonin in the human pineal gland. Brain Res Bull. 1998;47:271-276.
11. Samples JR, Krause G, Lewy AJ. Effect of melatonin on intraocular pressure. Curr Eye Res. 1988;7:649-653.
12. Viggiano SR, Koskela TK, Klee GG, et al. The effect of melatonin on aqueous humor flow in humans during the day. Ophthalmology. 1994; 101:326-331.
13. Koskela T, Brubaker RF. The nocturnal suppression of aqueous humor flow in humans is not blocked by bright light. Invest Ophthalmol Vis Sci. 1991;32:2504-2506.
14. Pintor J, Pelaez T, Hoyle CH, et al. Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor. Br J Pharmacol. 2003;138:831-836.
15. Wiechmann AF, Wirsig-Wiechmann CR. Melatonin receptor mRNA and protein expression in Xenopus laevis nonpigmented ciliary epithelial cells. Exp Eye Res. 2001;73:617-623.
16. Osborne NN. Serotonin and melatonin in the iris/ciliary processes and their involvement in intraocular pressure. Acta Neurobiol Exp (Warsz). 1994;54(Suppl):57-64.
17. Martin XD, Malina HZ, Brennan MC, et al. The ciliary body-the third organ found to synthesize indoleamines in humans. Eur J Ophthalmol. 1992;2:67-72.